Topic Menu

Newborn Screening

Contact Info

Newborn Screening Program

651-201-5466

800-664-7772 (toll-free)

health.newbornscreening@state.mn.us

Newborn Screening Panel and Timeline

Minnesota's Newborn Screening Panel

Disorder coming soon:

The following new conditions have been approved for addition to Minnesota's newborn screening panel.

Guanidinoacetate Methyltransferase (GAMT) Deficiency
Mucopolysaccharidosis Type II (MPS II)
Duchenne Muscular Dystrophy (DMD)

Implementation is currently in progress and screening has not yet begun.

The newborn screening panel refers to the list of disorders that newborns are screened for shortly after birth. In Minnesota, disorders are added to this panel by the Commissioner of Health with advice and recommendations from Minnesota's Advisory Committee on Heritable and Congenital Disorders.

Screening panels may vary from state to state. The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) provides national recommendations on which disorders should be screened for in all states to the Secretary of Health and Human Services. However, each state ultimately determines which disorders to include in its panel.

Newborn Screening Disorder Panel (PDF)

Minnesota's Newborn Screening Timeline

Primary targets of newborn screening	Year/date screening started
Phenylketonuria	1964
Congenital hypothyroidism	1968
Galactosemia	1974
Sickle cell disease	1988
Sickle-C disease	1988
S-βeta thalassemia	1988
Congenital adrenal hyperplasia	8/13/1992
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency	1/18/2001
3-Methylcrotonyl-CoA carboxylase deficiency	1/18/2001
Argininosuccinate acidemia	1/18/2001
Beta ketothiolase deficiency	1/18/2001
Carnitine uptake defect	1/18/2001
Citrullinemia type 1	1/18/2001
Glutaric acidemia type 1	1/18/2001
Homocystinuria	1/18/2001
Isovaleric acidemia	1/18/2001
Long-chain hydroxyacyl-CoA dehydrogenase deficiency	1/18/2001
Maple syrup urine disease	1/18/2001
Medium-chain acyl-CoA dehydrogenase deficiency	1/18/2001
Methylmalonic acidemia (3 types)	1/18/2001
Multiple CoA carboxylase deficiency	1/18/2001
Propionic acidemia	1/18/2001
Trifunctional protein deficiency	1/18/2001
Tyrosinemia type 1	1/18/2001
Very long-chain acyl-CoA dehydrogenase deficiency	1/18/2001
Biotinidase deficiency	10/26/2004
Cystic fibrosis	3/1/2006
Hearing loss	5/26/2007 (date screening was mandated)
Severe combined immunodeficiency	1/7/2013
Critical congenital heart disease	8/1/2013 (date screening was mandated)
X-linked adrenoleukodystrophy	2/6/2017
Mucopolysaccharidosis type I	8/1/2017
Pompe disease	8/1/2017
Spinal muscular atrophy	3/1/2018
Congenital cytomegalovirus (cCMV)	2/6/2023
Krabbe Disease	2/26/2024